Aclaris Therapeutics
ACRS
$1.18
Share price
0.04%
Change (1 day)
-85.57%
Change (1 year)
Categories
Aclaris Therapeutics (ACRS) - P/B ratio
P/B ratio as of May 2024 : 0.5350
According to Aclaris Therapeutics's latest financial reports the company has a price-to-book ratio of 0.5350.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Aclaris Therapeutics - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.4732 | -91.1% |
| 2022-12-31 | 5.31 | 17.8% |
| 2021-12-31 | 4.51 | -41.8% |
| 2020-12-31 | 7.75 | 591.19% |
| 2019-12-31 | 1.12 | -20.78% |
| 2018-12-31 | 1.42 | -58.06% |
| 2017-12-31 | 3.38 | -19.08% |
| 2016-12-31 | 4.17 | -28.93% |
| 2015-12-31 | 5.87 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | 407.26% | 🇺🇸 USA |